Table 1.
CF survival and mortality literature review—studies reporting longitudinal median survival age among people with CF, by country (n = 10 studies)
| Source | Study years | Population description | Ages | Study no. | Sub-group | Age of survival median (95% CI) | Longitudinal trend direction |
|---|---|---|---|---|---|---|---|
| United States | |||||||
| FitzSimmons 1994 and FitzSimmons 1993 [47, 48]a, b | 1969–1990 | U.S. CF Foundation Patient Registry | All ages | 7795 | 1969 | 14 | ↑ |
| 17,857 | 1990 | 27.6 | |||||
| Kulich 2003 [50] | 1985–1999 | U.S. CF Foundation Patient Registry | All ages | 31,012 | 1985, Males | 34.5 | ↑ |
| 1999, Males | 37.1 | ||||||
| 1985, Females | 31.5 | ||||||
| 1999, Females | 34.9 | ||||||
| Jackson 2011 [46] a | 1986–2008 | U.S. CF Foundation Patient Registry patients with death records | All ages | 8849 | 1986 | 26.7 (25.3–28.3) | ↑ |
| 2008 | 37.4 (35.0–40.1) | ||||||
| Stephenson 2017 [45] c | 1990–2013 | U.S. CF Foundation Patient Registry | All ages | 32,699 | 2009–2013, Includes post-transplant follow-up | 40.6 (39.1–41.8) | ↑ (data in figure only) |
| 2009–2013, Censoring at transplant | 44.0 | ||||||
| Ostrenga 2023 [49] a, d | 1986–2017 | U.S. CF Foundation Patient Registry linked to the National Death Index | All ages | 30,788 | 1986–1990 | 29.7 | ↑ |
| 2013–2017 | 45.8 | ||||||
| Canada | |||||||
| Corey 1996 [54] | 1970–1989 | Canadian Patient Data Registry | All ages | 3795 | 1970–1989, Males | 29.5 | ↑ |
| 1970–1974, Males | 26.6 | ||||||
| 1985–1989, Males | 36.7 | ||||||
| 1970–1989, Females | 21.3 | ||||||
| 1970–1974, Females | 19.7 | ||||||
| 1985–1989, Females | 27.8 | ||||||
| Stephenson 2015 [53] c | 1990–2012 | Canadian CF Registry | All ages | 5787 | 1990 | 31.9 (28.3–35.2) | ↑ |
| 2008–2012 | 49.7 (46.1–52.2) | ||||||
| Stephenson 2017 [45] c | 1990–2013 | Canadian CF Registry | All ages | 4662 | 2009–2013, Includes post-transplant follow-up | 50.9 (50.5–52.2) | ↑ (data in figure only) |
| 2009–2013, Censoring at transplant | 57.1 | ||||||
| France | |||||||
| Bellis 2007 [52] a | 1994–2003 | Observatoire National de la Mucoviscidose in mainland France and Reunion Island | All ages | n/s | 1994–1996 | 28.1 | ↑ |
| 2001–2003 | 36.4 | ||||||
| Ireland | |||||||
| Jackson 2011 [46] a | 1986–2008 | CF Registry of Ireland patients with death records | All ages | 421 | 1986 | 20.1 (13.0–34.4) | ↑ |
| 2008 | 35.2 (24.5-N/A) | ||||||
| Australia | |||||||
| Ruseckaite 2022 [51] a | 2005–2020 | Australian CF Data Registry | All ages | 4601 | 2005–2009 | 48.9 (44.7–53.5) | ↑ |
| 2016–2020 | 56.3 (53.0–60.4) | ||||||
| Japan | |||||||
| Kozawa 2023 [55] b | 1994–2022 | National epidemiological survey and Japan CF Registry | All ages | 132 | 2012 | 18.8 (16.6–21.1) | ↑ |
| 2022 | 25.2 (18.7–31.7) | ||||||
CF cystic fibrosis, CI confidence interval, N/A not available, N/S not stated, U.S. United States; ↑ = increasing over time; ↓ = decreasing over time
aData also reported for additional years; the first and last years of data available are presented in this table
bMedian survival age also reported by gender (males, females)
cData also reported for additional years in figure only
dMedian survival age also reported for CFFPR standard reporting with no linkage to NDI